Close
Smartlab Europe
Achema middle east

Press Releases

medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials

medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem. Clinical testing during new drug development is costly and time intensive for pharmaceutical and biotech companies....

BioAscent introduces the Compound Connect interface to connect drug discovery customers with their compounds

BioAscent, the leading provider of integrated drug discovery services, has introduced a new web-based interface for customers using its compound management services. The Compound Connect interface provides BioAscent customers with a secure online inventory, ordering and tracking system for...

Terumo Pharmaceutical Solutions expands CDMO services outside Japan for global market

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation and a leading manufacturer of injection, primary container, and infusion therapy devices, has announced it will expand its contract development and manufacturing services for parenteral drugs to global customers. Terumo is...

Silgan Dispensing Introduces Gemini BE Nasal Pump at CPHI Frankfurt

To help pharmaceutical brands deliver faster-to-market nasal spray solutions, Silgan Dispensing, a global leader in the design, development and distribution of highly engineered pumps and sprayers in the pharmaceutical, home and beauty markets, announces the launch of the Gemini™...

IFF to Highlight Industry-Leading Product Portfolio, Expertise at CPhI Frankfurt

IFF's Pharma Solutions division—backed by 300 years of combined cellulosic excipient experience and housing leading brands like Avicel® and METHOCEL™, plus a robust seaweed-based excipient portfolio —will showcase its deep technical expertise, commitment to customers and investment in its...

Foundational partnership with Paradigm4 enables Alnylam Pharmaceuticals to rapidly accelerate RNAi- based drug target discovery

Paradigm4’s REVEAL Integrative Analytics platform enables Alnylam Pharmaceuticals to discover novel, genetically-validated drug targets from population scale biobank genotype-phenotype datasets and underlies the extraordinary pace and productivity of Alnylam’s RNAi therapeutics pipeline. Using Paradigm4’s cloud-based scientific analytics platform and data...

Recipharm bolsters blow fill seal capabilities with Lab+

Global contract development and manufacturing organisation (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for low volume blow-fill-seal (BFS) filling at its facility in Kaysersberg, France. BFS is an automated manufacturing process where plastic ampoules...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »